Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 4, 2025Catheterization and Cardiovascular Interventions

Antithrombotic Therapy Selection and Association With Clinical Outcomes Following Valve‐in‐Valve Transcatheter Aortic Valve Replacement

View Full Paper
Ask AI
Bookmark
Share

Authors

HUHiroki UeyamaVBVasilis BabaliarosIBIsida Byku

Discussion

Loading...

Member takes

Overview

Analysis reveals no significant differences in clinical outcomes between antithrombotic therapies in patients undergoing transcatheter aortic valve replacement.

Key Points

  • No significant differences were found in clinical outcomes between antithrombotic strategies after transcatheter aortic valve replacement.
  • Over the follow-up, the presence of atrial fibrillation was significantly linked to anticoagulant therapy usage.
  • The observational analysis included 104 patients with 74 on combined antiplatelet and anticoagulant therapy.
  • The findings suggest the need for additional guidelines on antithrombotic therapy selection following transcatheter aortic valve replacement.

Cite This Study

Ueyama et al. (2025) studied this question.

synapsesocial.com/papers/6930dc6bea1aef094cca1edehttps://doi.org/10.1002/ccd.70383
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched one closely related paper. Consider it for comparative context:

  1. 1Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation2020 · 423 citations